Personal Genome Diagnostics is the first company to obtain a license to materials from a unique community registry and biorepository managed by Duke CTSI. The license marks a milestone for the MURDOCK Study, a longitudinal population health research program that enrolled its first participant in 2009. The registry and biorepository include samples and associated data from over 12,000 participants, based at CTSI’s Duke Kannapolis research site, now a part of the new Center for Precision Health (CPH).
The Duke University School of Medicine has announced that Svati H. Shah, MD, MS, MHS, has been named associate dean for translational research, effective immediately. Shah directs the Duke Center for Precision Health, a collaborative effort between CTSI and the Precision Genomics Collaboratory that includes CTSI’s research site at Duke Kannapolis and the OneDukeGen initiative.
Duke CTSI is pleased to present the 2023 CTSI Translational Impact Report, Partnering to Improve Health, Trust, and Equity in our Communities.
Through a collaboration designed to advance research in health equity and social drivers of health, the Duke Clinical and Translational Science Institute (CTSI) and the Center for Precision Health have partnered with the Center for Nursing Research at the Duke University School of Nursing (DUSON) to bring more than 20,000 biological samples and linked data from a community-based registry at Duke Kannapolis to investigators at DUSON.
The Biomarkers to Advance Clinical Phenotypes of Low Back Pain (BACk) project will build on a successful pilot study completed by Duke Ortho and CTSI in August. Like the pilot, recruitment for the BACk study will take place in Durham and Kannapolis, where CTSI operates the Duke Kannapolis research site on the North Carolina Research Campus.
Analysis of a COVID-19 research study based at CTSI’s Duke Kannapolis site found that education level, household income, and baseline intention were associated with longer times to vaccination, and the most common reasons for not being vaccinated were safety concerns, side effects, and vaccine effectiveness.
The Duke CTSI is proud to announce the appointment of Kanecia Zimmerman, MD, PhD, MPH, and Joe McClernon, PhD as faculty associate directors of the CTSI. Zimmerman will serve as the associate director of Engagement and Health Translation, and McClernon will serve as the associate director of Partnerships and Integration.
The Duke Clinical and Translational Science Institute (CTSI) is pleased to announce the launch of the Center for Precision Health (CPH), a collaboration that will harness the power of genomic, biomarker, and health data to transform patient care and population health.
Samples and data from the MURDOCK Study helped Duke University researchers identify new indicators of fracture risk among older adults with type 2 diabetes.
Using samples and data from the MURDOCK Study, Duke University researchers have found more evidence linking the disruption of a key metabolic pathway with the development of Alzheimer’s disease.